Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

15,000 heart attack survivors tracked for 5 years to uncover best recovery paths

NCT ID NCT05862103

Knowledge-focused Sponsor: Yu Bo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study follows 15,000 people who survived a heart attack and were part of an earlier project. Researchers will call participants at 3 and 5 years after leaving the hospital to check their health, medications, and whether they had any major heart problems like another heart attack, stroke, or heart failure. The goal is to learn which treatments and strategies used during the emergency and recovery period lead to the best long-term outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal which emergency and post-heart-attack strategies lead to better long-term outcomes, helping doctors improve care guidelines.
What could go wrong
This is an observational follow-up, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient care or other factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2022

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

AMI survivors who participated in the project "Construction and key technology research on the whole myocardial protection system for acute myocardial infarction" and completed 1-year visit

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit. * Telephone to obtain informed consent from the subjects/family members of the subjects. Exclusion Criteria: * Not available

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute myocardial infarction Adverse event

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    18 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beijing An Zhen Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

  • Beijing Chao-Yang Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, China

  • Daqing Oil Field Hospital

    RECRUITING

    Daqing, Heilongjiang, China

  • First Affiliated Hospital of Xinjiang Medical University

    RECRUITING

    Ürümqi, Xinjiang, China

  • General Hospital of Northern Theater Command of the Chinese People's Liberation Army

    RECRUITING

    Shenyang, Liaoning, China

  • Guangdong general hospital

    RECRUITING

    Guangzhou, Guangdong, China

  • Peking University First Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, China

  • Second hospital of hebei medical university

    RECRUITING

    Shijiazhuang, Hebei, China

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, Henan, China

  • The General Hospital of Tianjin Medical University

    RECRUITING

    Tianjin, Tianjin Municipality, China

  • The Second Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, Jiangxi, 330006, China

  • The Second Hospital of Jilin University

    RECRUITING

    Changchun, Jilin, 150056, China

  • The econd Affiliated Hospital of Dalian Medical University

    RECRUITING

    Dalian, Liaoning, China

  • The first affiliated hospital of Guangxi medical university

    RECRUITING

    Nanning, Guangxi, 530021, China

  • Tianjin Chest Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, China

  • Xijing Hospital of Air Force Military Medical University

    RECRUITING

    Xi’an, Shanxi, China

  • Xinqiao Hospital Army Medical University

    RECRUITING

    Chongqing, Sichuan, 400000, China

  • Zhongda Hospital Southeast University

    RECRUITING

    Nanjing, Jiangsu, 210009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.